Hanmi Science Co., Ltd. (KRX:008930)
37,450
-950 (-2.47%)
Mar 19, 2026, 11:19 AM KST
Hanmi Science Market Cap
Hanmi Science has a market cap or net worth of 2.6 trillion as of March 18, 2026. Its market cap has increased by 32.87% in one year.
Market Cap
2.60T
Enterprise Value
2.73T
Revenue
1.34T
Ranking
n/a
PE Ratio
34.59
Stock Price
37,450.00
Market Cap Chart
Since August 28, 1995, Hanmi Science's market cap has increased from 36.00B to 2.60T, an increase of 7,122.81%. That is a compound annual growth rate of 15.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 2.60T | 5.93% |
| Dec 30, 2025 | 2.45T | 23.09% |
| Dec 30, 2024 | 1.99T | -25.17% |
| Dec 28, 2023 | 2.66T | 20.78% |
| Dec 29, 2022 | 2.21T | -39.49% |
| Dec 30, 2021 | 3.65T | -27.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.58T |
| Celltrion | 43.78T |
| ALTEOGEN | 18.99T |
| Sam Chun Dang Pharm. | 16.98T |
| Orum Therapeutics | 2.96T |
| Hanall Biopharma | 2.72T |
| Celltrion Pharm | 2.67T |
| Hugel | 2.61T |